Search

Your search keyword '"Saponaro, Chiara"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Saponaro, Chiara" Remove constraint Author: "Saponaro, Chiara"
36 results on '"Saponaro, Chiara"'

Search Results

1. Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease

3. Bridging cultural and cognitive perspectives on similarity reasoning

6. The role of the glucagon‐FGF21 axis in improving beta cell function during glucose intolerance and SGLT2 inhibition.

8. The LIFE PERSUADED project approach on phthalates and bisphenol A biomonitoring in Italian mother-child pairs linking exposure and juvenile diseases

9. A NOVEL DERIVATIVE OF 2-PHENYL-PYRIDO[1,2-a]PYRIMIDIN-4-ONE INHIBITS ENDOTHELIAL CELL DYSFUNCTION AND SMOOTH MUSCLE CELL PROLIFERATION/ACTIVATION

10. L'acquisizione dell'italiano come seconda lingua da parte di bambini con mandarino o arabo come prima lingua.

11. The Central-Versus Peripheral-Mediated Effects of Liraglutide Enhancement on Insulin Secretion is Dependent on the Stage of Diabetes

16. Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals

17. 149-OR: Genetic Modulation of HNF1A Activity via SGLT2 Deficiency Leads to Transient Intermittent Hyperglycemia: Consequences for HNF1A-MODY

18. Conceptual representations of plurals: a production study on the collectivity and distributivity reading

19. Adipose tissue dysfunction and visceral fat are associated to hepatic insulin resistance and severity of NASH even in lean individuals

20. Peripheral Insulin Resistance Predicts Liver Damage in Nondiabetic Subjects With Nonalcoholic Fatty Liver Disease

21. Proglucagon-Derived Peptides Expression and Secretion in Rat Insulinoma INS-1 Cells

23. 1900-P: HNF1A Deficiency Leads to Perturbed Glucagon Secretion in Humans

24. Interindividual Heterogeneity of SGLT2 Expression and Function in Human Pancreatic Islets

25. Author Correction: Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD

26. Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD

28. The LIFE PERSUADED project approach on phthalates and bisphenol A biomonitoring in Italian mother-child pairs linking exposure and juvenile diseases.

29. Therapeutic agent for treatment of blood vessels

30. Agente terapeutico per il trattamento dei vasi sanguigni

31. Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease

34. Metabolomic analysis identifies new biomarkers of liver damage in NAFLD

36. Cardiometabolic risk and subclinical vascular damage assessment in idiopathic inflammatory myopathies: a challenge for the clinician.

Catalog

Books, media, physical & digital resources